LAMB2 and neoplasm: We previously evaluated laminin expression in diverse immune regimens, including immune stimulation with CFA, alloantigen stimulation with donor-specific splenocyte transfusion (DST), tolerance induction with DST plus anti-CD40L mAbs, and immune suppression with a progressively growing tumor.